Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency
- PMID: 12088939
- DOI: 10.1097/00000539-200207000-00006
Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency
Abstract
Serum potassium concentration should be measured immediately before operation to detect hyperkalemia in heart failure patients treated with spironolactone. Renal insufficiency, advanced age, potassium supplementation, decompensated congestive heart failure, and a spironolactone dose larger than 25 mg/d increase the risk of hyperkalemia as a consequence of spironolactone therapy.
Similar articles
-
Hyperkalemia during spironolactone use in patients with decompensated heart failure.Arq Bras Cardiol. 2008 Sep;91(3):177-82, 194-9. doi: 10.1590/s0066-782x2008001500009. Arq Bras Cardiol. 2008. PMID: 18853060 English, Portuguese.
-
Spironolactone therapy in heart failure patients with chronic kidney disease.Clin Cardiol. 2009 Oct;32(10):597. doi: 10.1002/clc.20670. Clin Cardiol. 2009. PMID: 19911355 Free PMC article. No abstract available.
-
Safety of spironolactone use in ambulatory heart failure patients.Clin Cardiol. 2009 Jun;32(6):347-8. doi: 10.1002/clc.20597. Clin Cardiol. 2009. PMID: 19569078 Free PMC article. No abstract available.
-
The risks and benefits of aldosterone antagonists.Curr Heart Fail Rep. 2005 Aug;2(2):65-71. doi: 10.1007/s11897-005-0011-5. Curr Heart Fail Rep. 2005. PMID: 16036053 Review.
-
Spironolactone in the treatment of congestive heart failure.Ann Pharmacother. 2000 Nov;34(11):1336-40. doi: 10.1345/aph.10104. Ann Pharmacother. 2000. PMID: 11098350 Review.
Cited by
-
Severe hyperkalemia requiring hospitalization: predictors of mortality.Crit Care. 2012 Nov 21;16(6):R225. doi: 10.1186/cc11872. Crit Care. 2012. PMID: 23171442 Free PMC article.
-
[Successful resuscitation of a patient with hyperkalemic cardiac arrest by emergency hemodiafiltration].Anaesthesist. 2005 Nov;54(11):1100-4. doi: 10.1007/s00101-005-0868-4. Anaesthesist. 2005. PMID: 15912333 German.
-
Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases.Pharm World Sci. 2009 Jun;31(3):387-93. doi: 10.1007/s11096-009-9288-x. Epub 2009 Mar 3. Pharm World Sci. 2009. PMID: 19255869
-
Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.BMJ. 2003 Jul 19;327(7407):147-9. doi: 10.1136/bmj.327.7407.147. BMJ. 2003. PMID: 12869459 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical